Company intelligence / Profile preview

Virtual Incision

Lincoln, Nebraska, United Statesvirtualincision.com ↗

Ownership: Private
Development stage: Commercial

Overview

The MIRA system received FDA marketing authorization in February 2024 as the first miniaturized robotic-assisted surgery device for adult colectomies. Clinical studies have demonstrated safety and efficacy for bowel resection; international trials are ongoing for benign hysterectomy. The company aims to expand into additional surgical indications with further clinical validation underway or planned

Therapeutic areas: OtherGastroenterologyWomen's Health
Modalities: DeviceRobotic-assisted surgery system (miniaturized robotic surgical device)
Industry: Surgical Medical Devices

Partnerships

Collaboration with University of Nebraska–Lincoln and University of Nebraska Medical Center foundersExploring technology integration with NVIDIA Isaac platform

Beyond the preview

Go deeper on Virtual Incision.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Virtual Incision.

Explore the full profile